Showing results (251-260 of 679) with videos related to
Sort By:
Pageof 68
Blood|August 13, 2011
ABT-737 is highly effective against molecular subgroups of multiple myelomaLinda Bodet, Patricia Gomez-Bougie, Cyrille Touzeau, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2008
Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du MyélomeOlivier Decaux, Laurence Lodé, Florence Magrangeas, et al.Journal of Hematology & Oncology|December 15, 2018
Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathwaysBenoît Tessoulin, Agnès Moreau-Aubry, Géraldine Descamps, et al.Haematologica|November 21, 2007
The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangementSteven Le Gouill, Pascaline Talmant, Cyrille Touzeau, et al.Clinical Epigenetics|November 3, 2020
DNA hydroxymethylation is associated with disease severity and persists at enhancers of oncogenic regions in multiple myelomaJean-Baptiste Alberge, Florence Magrangeas, Mirko Wagner, et al.Leukemia & Lymphoma|September 23, 2017
Carfilzomib-dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR studyHartmut Goldschmidt, Philippe Moreau, Heinz Ludwig, et al.Nature Cancer|August 31, 2023
Acquired resistance to a GPRC5D-directed T-cell engager in multiple myeloma is mediated by genetic or epigenetic target inactivationJennifer Derrien, Sarah Gastineau, Antoine Frigout, et al.Expert Review of Anticancer Therapy|June 9, 2015
Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myelomaPaul G Richardson, Jacob P Laubach, Sagar Lonial, et al.British Journal of Haematology|February 14, 2002
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemiaPatrice Chevallier, Dominique Penther, Hervé Avet-Loiseau, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 29, 2012
Autologous stem cell transplantation: an effective salvage therapy in multiple myelomaEmilie Lemieux, Cyrille Hulin, Denis Caillot, et al.Pageof 68